Literature DB >> 20400685

Involvement of A1 adenosine receptors in altered vascular responses and inflammation in an allergic mouse model of asthma.

Dovenia S Ponnoth1, Ahmed Nadeem, Stephen Tilley, S Jamal Mustafa.   

Abstract

Poor lung function and respiratory disorders like asthma have a positive correlation with the development of adverse cardiovascular events. Increased adenosine levels are associated with lung inflammation that could lead to altered vascular responses and systemic inflammation. We hypothesized that asthmatic lung inflammation has systemic effects through A(1) adenosine receptors (A(1)AR) and investigated the effects of aerosolized adenosine on vascular reactivity and inflammation, using A(1)AR knockout (A(1)KO) and corresponding wild-type (A(1)WT) mice that were divided into three experimental groups each: control (CON), allergen sensitized and challenged (SEN), and SEN + aerosolized adenosine (SEN + AD). Animals were sensitized with ragweed (200 microg ip; days 1 and 6), followed by 1% ragweed aerosol challenges (days 11 to 13). On day 14, the SEN + AD groups received one adenosine aerosol challenge (6 mg/ml) for 2 min, and aortae were collected on day 15. 5'-N-ethylcarboxamidoadenosine (NECA; nonselective adenosine analog) induced concentration-dependent aortic relaxation in the A(1)WT CON group, which was impaired in the A(1)WT SEN and SEN + AD groups. All groups of A(1)KO mice showed similar (no significant difference) concentration-dependent relaxation to NECA. The A(1)WT SEN and SEN + AD groups had a significantly higher contraction to selective A(1) agonist 2-chloro-N(6)-cyclopentyladenosine (CCPA) compared with the CON group. Western blot data showed that aortic A(1)AR expression was significantly increased in WT SEN and SEN + AD mice compared with CON mice. Gene expression of ICAM-1 and IL-5 was significantly increased in allergic A(1)WT aorta and were undetected in the A(1)KO groups. A(1)WT allergic mice had significantly higher airway hyperresponsiveness (enhanced pause) to NECA, with adenosine aerosol further enhancing it. In conclusion, allergic A(1)WT mice showed altered vascular reactivity, increased airway hyperresponsiveness, and systemic inflammation. These data suggest that A(1)AR is proinflammatory systemically in this model of allergic asthma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20400685      PMCID: PMC2904134          DOI: 10.1152/ajpheart.01090.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  59 in total

Review 1.  The cardiac effects of adenosine.

Authors:  L Belardinelli; J Linden; R M Berne
Journal:  Prog Cardiovasc Dis       Date:  1989 Jul-Aug       Impact factor: 8.194

2.  Do patients with severe asthma run an increased risk from ischaemic heart disease?

Authors:  K Torén; N B Lindholm
Journal:  Int J Epidemiol       Date:  1996-06       Impact factor: 7.196

3.  5'-adenosine monophosphate is the neutrophil-derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cell monolayers.

Authors:  J L Madara; T W Patapoff; B Gillece-Castro; S P Colgan; C A Parkos; C Delp; R J Mrsny
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

4.  Human mononuclear phagocytes express adenosine A1 receptors. A novel mechanism for differential regulation of Fc gamma receptor function.

Authors:  J E Salmon; N Brogle; C Brownlie; J C Edberg; R P Kimberly; B X Chen; B F Erlanger
Journal:  J Immunol       Date:  1993-09-01       Impact factor: 5.422

5.  Activated eosinophils evoke chloride secretion in model intestinal epithelia primarily via regulated release of 5'-AMP.

Authors:  M B Resnick; S P Colgan; T W Patapoff; R J Mrsny; C S Awtrey; C Delp-Archer; P F Weller; J L Madara
Journal:  J Immunol       Date:  1993-11-15       Impact factor: 5.422

6.  Myocardial contraction band lesions in patients with fatal asthma: possible neurocardiologic mechanisms.

Authors:  F W Drislane; M A Samuels; H Kozakewich; F J Schoen; R C Strunk
Journal:  Am Rev Respir Dis       Date:  1987-02

7.  Adenosine in bronchoalveolar lavage fluid in asthma.

Authors:  A G Driver; C A Kukoly; S Ali; S J Mustafa
Journal:  Am Rev Respir Dis       Date:  1993-07

8.  Rapid decline in FEV1. A new risk factor for coronary heart disease mortality.

Authors:  M S Tockman; J D Pearson; J L Fleg; E J Metter; S Y Kao; K G Rampal; L J Cruise; J L Fozard
Journal:  Am J Respir Crit Care Med       Date:  1995-02       Impact factor: 21.405

9.  Adenosine-induced vasoconstriction in vivo. Role of the mast cell and A3 adenosine receptor.

Authors:  R K Shepherd; J Linden; B R Duling
Journal:  Circ Res       Date:  1996-04       Impact factor: 17.367

10.  Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model.

Authors:  P S Foster; S P Hogan; A J Ramsay; K I Matthaei; I G Young
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more
  7 in total

Review 1.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

2.  Role of angiotensin II type 1 (AT1) and type 2 (AT2) receptors in airway reactivity and inflammation in an allergic mouse model of asthma.

Authors:  Mehaben Patel; Mangesh Kurade; Sahith Rajalingam; Riya Bhavsar; S Jamal Mustafa; Dovenia S Ponnoth
Journal:  Immunopharmacol Immunotoxicol       Date:  2019-05-07       Impact factor: 2.730

Review 3.  Adenosine receptors and vascular inflammation.

Authors:  Dovenia S Ponnoth; S Jamal Mustafa
Journal:  Biochim Biophys Acta       Date:  2010-09-09

4.  Airway Exposure to Modified Multi-walled Carbon Nanotubes Perturbs Cardiovascular Adenosinergic Signaling in Mice.

Authors:  Leslie C Thompson; Nicole L Sheehan; Dianne M Walters; Robert M Lust; Jared M Brown; Christopher J Wingard
Journal:  Cardiovasc Toxicol       Date:  2019-04       Impact factor: 3.231

Review 5.  Purinergic receptors in ocular inflammation.

Authors:  Ana Guzman-Aranguez; Xavier Gasull; Yolanda Diebold; Jesús Pintor
Journal:  Mediators Inflamm       Date:  2014-07-14       Impact factor: 4.711

Review 6.  Adenosine Receptors As Drug Targets for Treatment of Pulmonary Arterial Hypertension.

Authors:  Allan K N Alencar; Guilherme C Montes; Eliezer J Barreiro; Roberto T Sudo; Gisele Zapata-Sudo
Journal:  Front Pharmacol       Date:  2017-12-04       Impact factor: 5.810

Review 7.  Purinergic Signaling in Mast Cell Degranulation and Asthma.

Authors:  Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Front Pharmacol       Date:  2017-12-22       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.